Additionally, WIF1 has been found to enhance chemosensitivity of prostate cancer to certain anticancer drugs, including paclitaxel and etoposide, suggesting a potential role for WIF1 in improving treatment outcomes [81]. Here, WIF1 is linked to Familial prostate cancer.